Michael Schmidt
Stock Analyst at Guggenheim
(4.95)
# 168
Out of 5,108 analysts
522
Total ratings
54%
Success rate
29%
Average return
Main Sectors:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintained: Buy | $58 → $56 | $33.48 | +67.26% | 10 | Nov 5, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $275 → $298 | $190.27 | +56.62% | 26 | Nov 5, 2026 | |
| GMAB Genmab | Maintained: Buy | $58 → $80 | $56.49 | +41.62% | 15 | Oct 30, 2026 | |
| INCY Incyte | Reiterated: Buy | $150 | $116.80 | +28.42% | 44 | Oct 27, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $18 → $30 | $15.95 | +88.09% | 15 | Oct 26, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $40 | $15.21 | +162.98% | 3 | Oct 22, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $52 | $31.96 | +62.70% | 8 | Oct 6, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $28 | $10.87 | +157.59% | 14 | Oct 1, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $35 | $22.53 | +55.35% | 13 | Sep 24, 2026 | |
| CMPX Compass Therapeutics | Rated: Buy | $12 → $4 | $0.7562 | +428.96% | 7 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.36 | +257.14% | 5 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $5 | $1.49 | +235.57% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.70 | +39.37% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $14.98 | +40.19% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $18.29 | +91.36% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $2.29 | +511.35% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.99 | +402.51% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $9.66 | +24.22% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $78 | $45.08 | +73.03% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $420 → $430 | $371.56 | +15.73% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.90 | - | 16 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.48 | - | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.53 | - | 7 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $33.80 | +6.51% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.09 | +474.16% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $66.20 | - | 43 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $122.60 | n/a | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $19.47 | n/a | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0261 | n/a | 15 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.56 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $22.30 | n/a | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.38 | n/a | 9 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $31.27 | n/a | 2 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.36 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.02 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.25 | n/a | 6 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.77 | n/a | 7 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $43 | $14.15 | n/a | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 | $3.58 | n/a | 6 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.99 | n/a | 3 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.17 | n/a | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.17 | n/a | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $63 | $37.23 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $460.73 | n/a | 2 | Sep 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $29.21 | n/a | 13 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.82 | n/a | 2 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $140 → $85 | $10.54 | n/a | 5 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.29 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $25.30 | n/a | 10 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $15 | $0.6815 | n/a | 5 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.28 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $0.003 | n/a | 6 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $44.39 | n/a | 9 | Oct 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $174.00 | n/a | 12 | Oct 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $1.5 | $1.05 | n/a | 5 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.8798 | n/a | 8 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.23 | n/a | 3 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.63 | n/a | 3 | Aug 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $45.37 | n/a | 4 | Oct 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $181 | $207.83 | n/a | 5 | Aug 6, 2014 |
UroGen Pharma
Nov 5, 2026
Maintained: Buy
Price Target: $58 → $56
Current: $33.48
Upside: +67.26%
Revolution Medicines
Nov 5, 2026
Maintained: Buy
Price Target: $275 → $298
Current: $190.27
Upside: +56.62%
Genmab
Oct 30, 2026
Maintained: Buy
Price Target: $58 → $80
Current: $56.49
Upside: +41.62%
Incyte
Oct 27, 2026
Reiterated: Buy
Price Target: $150
Current: $116.80
Upside: +28.42%
ArriVent BioPharma
Oct 26, 2026
Reiterated: Buy
Price Target: $18 → $30
Current: $15.95
Upside: +88.09%
BlossomHill Therapeutics
Oct 22, 2026
Reiterated: Buy
Price Target: $40
Current: $15.21
Upside: +162.98%
Cogent Biosciences
Oct 6, 2026
Reiterated: Buy
Price Target: $52
Current: $31.96
Upside: +62.70%
Monte Rosa Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $28
Current: $10.87
Upside: +157.59%
Tango Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $35
Current: $22.53
Upside: +55.35%
Compass Therapeutics
Sep 22, 2026
Rated: Buy
Price Target: $12 → $4
Current: $0.7562
Upside: +428.96%
Sep 8, 2026
Reiterated: Buy
Price Target: $12
Current: $3.36
Upside: +257.14%
Aug 14, 2026
Rated: Buy
Price Target: $10 → $5
Current: $1.49
Upside: +235.57%
Aug 14, 2026
Reiterated: Buy
Price Target: $40
Current: $28.70
Upside: +39.37%
Aug 12, 2026
Reiterated: Buy
Price Target: $20 → $21
Current: $14.98
Upside: +40.19%
Aug 12, 2026
Reiterated: Buy
Price Target: $35
Current: $18.29
Upside: +91.36%
Aug 7, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $2.29
Upside: +511.35%
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $1.99
Upside: +402.51%
Aug 6, 2026
Reiterated: Buy
Price Target: $14 → $12
Current: $9.66
Upside: +24.22%
Aug 5, 2026
Reiterated: Buy
Price Target: $80 → $78
Current: $45.08
Upside: +73.03%
Aug 5, 2026
Reiterated: Buy
Price Target: $420 → $430
Current: $371.56
Upside: +15.73%
Jul 17, 2026
Rated: Hold
Price Target: n/a
Current: $7.90
Upside: -
Jul 1, 2026
Rated: Hold
Price Target: n/a
Current: $2.48
Upside: -
Jun 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.53
Upside: -
May 5, 2026
Reiterated: Buy
Price Target: $36
Current: $33.80
Upside: +6.51%
Mar 11, 2026
Reiterated: Buy
Price Target: $12
Current: $2.09
Upside: +474.16%
Feb 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $66.20
Upside: -
Aug 11, 2025
Reiterated: Buy
Price Target: $60
Current: $122.60
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $19.47
Upside: n/a
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0261
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $9.56
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $22.30
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $2.38
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $31.27
Upside: n/a
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $6.36
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.02
Upside: n/a
Jan 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.25
Upside: n/a
Dec 7, 2023
Reiterated: Buy
Price Target: n/a
Current: $7.77
Upside: n/a
Oct 3, 2023
Reiterated: Buy
Price Target: $40 → $43
Current: $14.15
Upside: n/a
Jun 27, 2023
Downgraded: Hold
Price Target: $20
Current: $3.58
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $15
Current: $8.99
Upside: n/a
Jan 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $2.17
Upside: n/a
Apr 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $1.17
Upside: n/a
Feb 25, 2021
Reiterated: Buy
Price Target: $66 → $63
Current: $37.23
Upside: n/a
Sep 18, 2020
Reiterated: Hold
Price Target: n/a
Current: $460.73
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $44
Current: $29.21
Upside: n/a
Jun 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $28.82
Upside: n/a
Sep 17, 2018
Initiated Coverage: Buy
Price Target: $140 → $85
Current: $10.54
Upside: n/a
Nov 30, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.29
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $27 → $23
Current: $25.30
Upside: n/a
Nov 11, 2016
Reiterated: Hold
Price Target: $1.5 → $15
Current: $0.6815
Upside: n/a
Nov 10, 2016
Reiterated: Hold
Price Target: $5
Current: $4.28
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $3 → $2
Current: $0.003
Upside: n/a
Oct 9, 2016
Reiterated: Hold
Price Target: $36
Current: $44.39
Upside: n/a
Oct 5, 2016
Reiterated: Hold
Price Target: $40
Current: $174.00
Upside: n/a
Sep 20, 2016
Reiterated: Hold
Price Target: $4 → $1.5
Current: $1.05
Upside: n/a
Sep 6, 2016
Reiterated: Buy
Price Target: $18
Current: $0.8798
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: n/a
Current: $13.23
Upside: n/a
Aug 16, 2016
Reiterated: Buy
Price Target: $28
Current: $3.63
Upside: n/a
Oct 6, 2015
Reiterated: Buy
Price Target: n/a
Current: $45.37
Upside: n/a
Aug 6, 2014
Rated: Buy
Price Target: $177 → $181
Current: $207.83
Upside: n/a